Christopher B. Fox
- Immunology top 0.5%
- Immunotherapy and Immune Responses 31
- Immune Response and Inflammation 25
- Immune Cell Function and Interaction 9
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research 12
- Microbiology top 1%
- Pharmaceutical Science top 1%
- Virology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 12
-
- RNA Interference and Gene Delivery 11
- Lipid Membrane Structure and Behavior 11
-
- Influenza Virus Research Studies 9
- Co-authors
- Steven G. ReedMark T. OrrMalcolm S. DuthieDerek T. O’HaganThomas S. VedvickJoel M. HarrisHillarie Plessner WindishRhea N. Coler
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Christopher B. Fox
105 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Immunology 2.8k
- Infectious Diseases 1.3k
- Microbiology 324
- Pharmaceutical Science 288
- Virology 178
Countries citing papers authored by Christopher B. Fox
This map shows the geographic impact of Christopher B. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher B. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher B. Fox more than expected).
Fields of papers citing papers by Christopher B. Fox
This network shows the impact of papers produced by Christopher B. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher B. Fox. The network helps show where Christopher B. Fox may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher B. Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 20 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 18 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 56 | |
| 14 | 2020 | 11 | |
| 15 | 2019 | 10 | |
| 16 | 2018 | 37 | |
| 17 | 2017 | 20 | |
| 18 | 2014 | 39 | |
| 19 | 2013 | 41 | |
| 20 | 2012 | 15 |
About Christopher B. Fox
Christopher B. Fox is a scholar working on Immunology, Infectious Diseases, Microbiology, Pharmaceutical Science and Virology, having authored 110 papers that have together received 5.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (31 papers), Immune Response and Inflammation (25 papers), SARS-CoV-2 and COVID-19 Research (12 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), RNA Interference and Gene Delivery (11 papers), Lipid Membrane Structure and Behavior (11 papers), Influenza Virus Research Studies (9 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Immunology (2.8k citations), Infectious Diseases (1.3k citations), Microbiology (324 citations), Pharmaceutical Science (288 citations) and Virology (178 citations). Christopher B. Fox has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Steven G. Reed, Mark T. Orr, Malcolm S. Duthie, Derek T. O’Hagan, Thomas S. Vedvick, Joel M. Harris, Hillarie Plessner Windish, Rhea N. Coler, Harm HogenEsch and Darrick Carter. Their work appears in journals such as Vaccine, npj Vaccines, PLoS ONE, Journal of Pharmaceutical Sciences and Colloids and Surfaces B Biointerfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.